Moneycontrol PRO
HomeNewsAartidrugs

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Aarti Drugs buyback: Here's what investors should do

    Aarti Drugs buyback: Here's what investors should do

    Company is expected to complete the buyback process by April-end (2 months estimated on a higher side).

  • Market remains rangebound, but these 7 stocks can give 7-75% returns in a year

    Market remains rangebound, but these 7 stocks can give 7-75% returns in a year

    Market is trading in range but falling crude oil prices and appreciating rupee are helping the market to trade on the positive side

  • Aarti Drugs gains 2% ahead of board meet for buyback

    Aarti Drugs gains 2% ahead of board meet for buyback

    A meeting of board of directors of the company is scheduled to be held on January 08 to consider proposal of buyback of the fully paid-up equity shares of the company including matters related/incidental thereto.

  • Nifty may see selling pressure, support at 9520; 4 stocks to buy today: Prakash Gaba

    Nifty may see selling pressure, support at 9520; 4 stocks to buy today: Prakash Gaba

    Prakash Gaba of prakashgaba.com is of the view that crucial support for the Nifty is at 9580-9520 and the resistance is at 9700- 9724. "Aarti Drugs, AIA Engineering, Dewan Housing Finance and Capital First are bullish plays for the day," he adds.

  • Here are top 10 stocks to focus on March 24

    Here are top 10 stocks to focus on March 24

    Here are top 10 stocks to focus on March 24 – HDFC, Wockhardt, Geometric, GMR Infra, Sun Pharma, Ranbaxy, Hero Moto, JSPL, Adani Power and Aarti Drugs.

  • Here are top 10 stocks to focus on March 18

    Here are top 10 stocks to focus on March 18

    Here are top 10 stocks to focus on March 18 - IOC, Tech Mahindra, Sesa Sterlite, Reliance Infra, Mahindra & Mahindra, M&M Financial, Bhushan Steel, SBI, Gujarat Fluoro and Aarti Drugs

  • Aarti Drugs can move to Rs 200: SP Tulsian

    Aarti Drugs can move to Rs 200: SP Tulsian

    Aarti Drugs can move to Rs 200 in the next 6 months, says SP Tulsian of sptulsian.com. Their Q1 earnings came well. They posted a topline of Rs 190 crore and EPS of Rs 7.90 for the quarter, while EPS for whole of FY12 was close to Rs 18 or maybe sub-Rs 18.

  • Tulsian's multibaggers:IL&FS Engineering, Aarti Drugs

    Tulsian's multibaggers:IL&FS Engineering, Aarti Drugs

    In an interview with CNBC-TV18 SP Tulsian of sptulsian.com picked IL&FS Engineering and Aarti Drugs as multibagger stocks. He is bullish on both the stocks and expects them to fetch better returns ahead.

  • Bulls Eye: Buy Finolex Cable, HUL, Infosys

    Bulls Eye: Buy Finolex Cable, HUL, Infosys

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347